SYNJARDY
Marketedupdated 2mo agoby Boehringer Ingelheim Corp
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 37 investigational indications.
indications
investigational
Type 2 Diabetes
all catalysts(47)
approval · 46
phase 1 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that